Skip to content

Drug interactions

Idarubicin + Sotorasib

Severity: Moderate

Idarubicin and Sotorasib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sotorasib has been shown to inhibit P-glycoprotein, so higher idarubicin exposure is plausible rather than lower. The clinical consequence is poorly characterised and could include more myelosuppression or cardiotoxicity.

What this interaction means in plain words

Idarubicin and Sotorasib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Idarubicin belongs to Oncology; Sotorasib belongs to Oncology.

Evidence level: Low

Why it happens

Sotorasib inhibits P-gp, which may reduce efflux of idarubicin; the clinical effect has not been well studied.

What to do

Monitor blood counts and cardiac function. Reduce idarubicin dose if excess toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idarubicin and Sotorasib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idarubicin with Sotorasib?

MediHelp rates the interaction as moderate. Idarubicin and Sotorasib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sotorasib has been shown to inhibit P-glycoprotein, so higher idarubicin exposure is plausible rather than lower. The clinical consequence is poorly characterised and could include more myelosuppression or cardiotoxicity.

How serious is the interaction between Idarubicin and Sotorasib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac function. Reduce idarubicin dose if excess toxicity develops.

What other medicines interact with Idarubicin?

MediHelp also lists interactions of Idarubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclophosphamide. The full list is on the Idarubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in